Skip to content
10-Q/A

Quarterly Report

Bio Essence Corp BIOE

0001213900-24-103410

← back to feed
Filed
Nov 27, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Nov 27, 2024 38.01M sh
Shares Diluted Q2 2024 · Jun 30, 2024 38.01M sh
Shares Diluted Q2 2024 · Jun 30, 2024 38.01M sh
Shares Diluted Q2 2024 · Jun 30, 2023 34.71M sh
Shares Diluted Q2 2024 · Jun 30, 2023 33.87M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$156.34K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$476.73K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $9.49K
Stockholders Equity restated Q2 2024 · Jun 30, 2024 −$1.74M
Stockholders Equity restated Q2 2024 · Mar 31, 2024 −$1.53M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$1.66M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$1.15M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$3.42M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$3.24M
Current Liabilities Q2 2024 · Jun 30, 2024 $3.11M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.45M
Total Liabilities Q2 2024 · Jun 30, 2024 $3.84M
Total Liabilities Q2 2024 · Dec 31, 2023 $4.42M
Current Assets Q2 2024 · Jun 30, 2024 $916.67K
Current Assets Q2 2024 · Dec 31, 2023 $300K
Total Assets Q2 2024 · Jun 30, 2024 $2.1M
Total Assets Q2 2024 · Dec 31, 2023 $2.76M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.01
Eps Diluted Q2 2024 · Jun 30, 2024 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.01
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.01
Eps Basic Q2 2024 · Jun 30, 2024 −$0.01
Eps Basic Q2 2024 · Jun 30, 2024 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 −$0.01
Eps Basic Q2 2024 · Jun 30, 2023 −$0.01
Sga Expense Q2 2024 · Jun 30, 2024 $194.2K
Sga Expense Q2 2024 · Jun 30, 2024 $346.03K
Sga Expense restated Q2 2024 · Jun 30, 2023 $43.16K
Sga Expense restated Q2 2024 · Jun 30, 2023 $67.47K
Net Income Q2 2024 · Jun 30, 2024 −$215.68K
Net Income Q2 2024 · Jun 30, 2024 −$81.74K
Net Income restated Q2 2024 · Mar 31, 2024 $133.94K
Net Income Q2 2024 · Jun 30, 2023 −$284.52K
Net Income Q2 2024 · Jun 30, 2023 −$463.35K
Net Income Q2 2024 · Mar 31, 2023 −$178.84K
Operating Income Q2 2024 · Jun 30, 2024 −$165.01K
Operating Income Q2 2024 · Jun 30, 2024 −$316.84K
Operating Income restated Q2 2024 · Jun 30, 2023 −$43.16K
Operating Income restated Q2 2024 · Jun 30, 2023 −$67.47K
Gross Profit Q2 2024 · Jun 30, 2024 $29.19K
Gross Profit Q2 2024 · Jun 30, 2024 $29.19K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $12.51K
Cost Of Revenue Q2 2024 · Jun 30, 2024 $12.51K
Revenue Q2 2024 · Jun 30, 2024 $41.7K
Revenue Q2 2024 · Jun 30, 2024 $41.7K